Market & Portfolio Update - September 2018
Market & Portfolio Update - September 2018
Share markets rose further in September, shrugging off the unresolved NZ election and war of words between the United States and North Korea. The positive underlying factors driving the world economy have continued to show, supporting investor confidence and fund returns.
In a flashback to themes from earlier in the year, Donald Trump launched a much-anticipated new plan to cut taxes for US businesses, adding a potential further positive for share investors. Given the positive economic outlook, Janet Yellen, chair of the US Federal Reserve, also reconfirmed expectations for interest rates to continue to gradually rise, which would be reinforced if Trump’s tax plan is implemented.
We have bought shares in horticultural company Scales Corporation within your NZ share investments. The purchase took advantage of a dip in the company’s share price, and we expect its earnings to rise over time as it benefits from growing apple sales in its key export markets of Asia and the Middle East.
Disclaimer: This article has been prepared for the purpose of providing general information, without taking into consideration any particular investor’s objectives, financial situation or needs. Any opinions contained in it are held as at the report date and are subject to change without notice. This document is solely for the use of the party to whom it is provided.
Market & Portfolio Update - February 2024
Markets have started 2024 on the front foot, with global shares up almost 10% in New Zealand dollar terms. The theme of AI integration and its impact on companies continues to play an important role, with technology businesses leading the market.
A Safety Net in the Sun: Health Insurance's Vital Role in Melanoma Treatment
Melanoma, a type of skin cancer, presents a significant health concern in New Zealand, with the country ranking second globally in skin cancer diagnosis rates, closely following Australia. The high incidence of skin cancer in New Zealand can be attributed to several factors, including elevated UV levels compared to equivalent latitudes in the Northern Hemisphere, with a 40% increase in UV radiation during the summer months due to the sun's elliptical orbit[1]. Despite efforts to raise awareness about sun protection measures, the fatality rate for diagnosed cases in New Zealand is notably higher than that of neighbouring countries.